BACKGROUND: Aortic valve calcification is a progressive process resembling ossification. Recent evidence indicates that the sympathetic nervous system plays an important role in regulating bone deposition and resorption through the beta2-adrenergic receptors (beta2-ARs). The aim of this study is to determine the level and pattern of expression of beta2-ARs in human valve interstitial cells (ICs) and assess their influence on differentiation of the cells into an osteoblast-like phenotype. METHODS AND RESULTS: Immunohistochemical analysis demonstrated a high expression of beta2-ARs, beta1-ARs, beta3-AR,s and receptor activator of nuclear factor-kappaB (RANK) in calcified aortic valves. The expression of beta2-ARs and beta1-ARs mRNA was assessed by real-time TaqMan PCR in cultures of human aortic valve ICs. Human valve ICs treated with the selective beta2-AR agonist, salmeterol, in the presence of osteogenic medium showed a significant 5-fold decrease in the alkaline phosphatase (ALP) activity in comparison to cells treated with osteogenic medium only (P<0.05). Immunocytochemical staining of the valve ICs showed a concomitant reduction in osteocalcin expression. In addition, other beta2-AR agonists caused a reduction in the protein expression of bone markers including ALP, Cbfa-1, and periostin. Human valve ICs treated with norepinephrine, in the presence of osteogenic medium, did not show a significant reduction in the ALP activity. CONCLUSIONS: These findings suggest an important role of the beta2-ARs in regulating valve calcification and may identify potential therapeutic targets.
BACKGROUND: Aortic valve calcification is a progressive process resembling ossification. Recent evidence indicates that the sympathetic nervous system plays an important role in regulating bone deposition and resorption through the beta2-adrenergic receptors (beta2-ARs). The aim of this study is to determine the level and pattern of expression of beta2-ARs in human valve interstitial cells (ICs) and assess their influence on differentiation of the cells into an osteoblast-like phenotype. METHODS AND RESULTS: Immunohistochemical analysis demonstrated a high expression of beta2-ARs, beta1-ARs, beta3-AR,s and receptor activator of nuclear factor-kappaB (RANK) in calcified aortic valves. The expression of beta2-ARs and beta1-ARs mRNA was assessed by real-time TaqMan PCR in cultures of human aortic valve ICs. Human valve ICs treated with the selective beta2-AR agonist, salmeterol, in the presence of osteogenic medium showed a significant 5-fold decrease in the alkaline phosphatase (ALP) activity in comparison to cells treated with osteogenic medium only (P<0.05). Immunocytochemical staining of the valve ICs showed a concomitant reduction in osteocalcin expression. In addition, other beta2-AR agonists caused a reduction in the protein expression of bone markers including ALP, Cbfa-1, and periostin. Human valve ICs treated with norepinephrine, in the presence of osteogenic medium, did not show a significant reduction in the ALP activity. CONCLUSIONS: These findings suggest an important role of the beta2-ARs in regulating valve calcification and may identify potential therapeutic targets.
Authors: Doan Tm Ngo; Irene Stafford; Aaron L Sverdlov; Weier Qi; Ronald D Wuttke; Yuan Zhang; Darren J Kelly; Helen Weedon; Malcolm D Smith; Jennifer A Kennedy; John D Horowitz Journal: Br J Pharmacol Date: 2011-02 Impact factor: 8.739
Authors: Paige Snider; Robert B Hinton; Ricardo A Moreno-Rodriguez; Jian Wang; Rhonda Rogers; Andrew Lindsley; Fang Li; David A Ingram; Donald Menick; Loren Field; Anthony B Firulli; Jeffery D Molkentin; Roger Markwald; Simon J Conway Journal: Circ Res Date: 2008-02-22 Impact factor: 17.367
Authors: Jordan D Miller; Robert M Weiss; Kristine M Serrano; Robert M Brooks; Christopher J Berry; Kathy Zimmerman; Stephen G Young; Donald D Heistad Journal: Circulation Date: 2009-05-11 Impact factor: 29.690
Authors: Jeroen C W Siero; Nick F Ramsey; Hans Hoogduin; Dennis W J Klomp; Peter R Luijten; Natalia Petridou Journal: PLoS One Date: 2013-01-15 Impact factor: 3.240